Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes

Seminars in Cell and Developmental Biology

Volumn 40, Issue , 2015, Pages 41-51

  Minciacchi, Valentina R ^a   Freeman, Michael R ^a,b,c   Di Vizio, Dolores ^a,b,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biogenesis; Exosomes; Extracellular communication; Extracellular vesicles; Large oncosomes; Microvesicles

Indexed keywords

CELLUBREVIN; ESCRT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; SNARE PROTEIN; SYNAPTOBREVIN; SYNAPTOBREVIN 1; SYNAPTOBREVIN 2;

BASEMENT MEMBRANE; BIOGENESIS; CANCER CELL; CANCER RESISTANCE; CELL COMMUNICATION; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL ORGANELLE; CYTOPATHOLOGY; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOSOME; EXOSOME; EXTRACELLULAR SPACE; FLOW CYTOMETRY; IMAGING SOFTWARE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LARGE ONCOSOME; LIPID BILAYER; MEMBRANE MICROPARTICLE; METASTASIS; MULTIVESICULAR BODY; PHAGOCYTOSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CHEMISTRY; CLASSIFICATION; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ANIMALS; CELL-DERIVED MICROPARTICLES; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84929292388     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.02.010     Document Type: Review

References (151)

1. Douglas R.M., Goddard G.V. Long-term potentiation of the perforant path-granule cell synapse in the rat hippocampus. Brain Res 1975, 86:205-215.
2. Edlund M., Sung S.Y., Chung L.W. Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem 2004, 91:686-705.
3. Mikels A.J., Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006, 25:7461-7468.
4. Singh A.B., Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005, 17:1183-1193.
5. Al-Nedawi K., Meehan B., Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 2009, 8:2014-2018.
6. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
7. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2013, 2.
8. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
9. Tetta C., Ghigo E., Silengo L., Deregibus M.C., Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2013, 44:11-19.
10. Turturici G., Tinnirello R., Sconzo G., Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 2014, 306:C621-C633.
11. Peinado H., Aleckovic M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012, 18:883-891.
12. Jang S.C., Kim S.R., Yoon Y.J., Park K.S., Kim J.H., Lee J., et al. In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria. Small 2014, 11:456-461.
13. Di Vizio D., Morello M., Dudley A.C., Schow P.W., Adam R.M., Morley S., et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012, 181:1573-1584.
14. Morello M., Minciacchi V.R., de Candia P., Yang J., Posadas E., Kim H., et al. Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle 2013, 12:3526-3536.
15. Danesh A., Inglis H.C., Jackman R.P., Wu S., Deng X., Muench M.O., et al. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 2014, 123:687-696.
16. Aatonen M.T., Ohman T., Nyman T.A., Laitinen S., Gronholm M., Siljander P.R. Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 2014, 3.
17. Yu X., Huang C., Song B., Xiao Y., Fang M., Feng J., et al. CD4+CD25+ regulatory T cells-derived exosomes prolonged kidney allograft survival in a rat model. Cell Immunol 2013, 285:62-68.
18. Thery C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002, 3:1156-1162.
19. Luga V., Wrana J.L. Tumor-stroma interaction: revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. Cancer Res 2013, 73:6843-6847.
20. Ju R., Zhuang Z.W., Zhang J., Lanahan A.A., Kyriakides T., Sessa W.C., et al. Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways. J Biol Chem 2014, 289:510-519.
21. Riches A., Campbell E., Borger E., Powis S. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway. Eur J Cancer 2014, 50:1025-1034.
22. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94:3791-3799.
23. Biller S.J., Schubotz F., Roggensack S.E., Thompson A.W., Summons R.E., Chisholm S.W. Bacterial vesicles in marine ecosystems. Science 2014, 343:183-186.
24. Kowal J., Tkach M., Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol 2014, 29C:116-125.
25. Booth A.M., Fang Y., Fallon J.K., Yang J.M., Hildreth J.E., Gould S.J. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 2006, 172:923-935.
26. Morvan J., Rinaldi B., Friant S. Pkh1/2-dependent phosphorylation of Vps27 regulates ESCRT-I recruitment to endosomes. Mol Biol Cell 2012, 23:4054-4064.
27. Adell M.A., Vogel G.F., Pakdel M., Muller M., Lindner H., Hess M.W., et al. Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol 2014, 205:33-49.
28. Buschow S.I., Nolte-'t Hoen E.N., van Niel G., Pols M.S., ten Broeke T., Lauwen M., et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 2009, 10:1528-1542.
29. Colombo M., Moita C., van Niel G., Kowal J., Vigneron J., Benaroch P., et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 2013, 126:5553-5565.
30. Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A., et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012, 14:677-685.
31. Romancino D.P., Paterniti G., Campos Y., De Luca A., Di Felice V., d'Azzo A., et al. Identification and characterization of the nano-sized vesicles released by muscle cells. FEBS Lett 2013, 587:1379-1384.
32. Marsh M., van Meer G. Cell biology. No ESCRTs for exosomes. Science 2008, 319:1191-1192.
33. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
34. Kirby R.L., McLean A.D., Eastwood B.J. Influence of caster diameter on the static and dynamic forward stability of occupied wheelchairs. Arch Phys Med Rehabil 1992, 73:73-77.
35. Laulagnier K., Motta C., Hamdi S., Roy S., Fauvelle F., Pageaux J.F., et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J 2004, 380:161-171.
36. Ghossoub R., Lembo F., Rubio A., Gaillard C.B., Bouchet J., Vitale N., et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 2014, 5:3477.
37. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009, 10:513-525.
38. Tauro B.J., Mathias R.A., Greening D.W., Gopal S.K., Ji H., Kapp E.A., et al. Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteomics 2013, 12:2148-2159.
39. Savina A., Vidal M., Colombo M.I. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 2002, 115:2505-2515.
40. Savina A., Fader C.M., Damiani M.T., Colombo M.I. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005, 6:131-143.
41. Hsu C., Morohashi Y., Yoshimura S., Manrique-Hoyos N., Jung S., Lauterbach M.A., et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 2010, 189:223-232.
42. Ostrowski M., Carmo N.B., Krumeich S., Fanget I., Raposo G., Savina A., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010, 12:19-30. sup pp 1-13.
43. Bobrie A., Krumeich S., Reyal F., Recchi C., Moita L.F., Seabra M.C., et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 2012, 72:4920-4930.
44. Fader C.M., Sanchez D.G., Mestre M.B., Colombo M.I. TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 2009, 1793:1901-1916.
45. Choi D.S., Lee J.M., Park G.W., Lim H.W., Bang J.Y., Kim Y.K., et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007, 6:4646-4655.
46. Mathivanan S., Lim J.W., Tauro B.J., Ji H., Moritz R.L., Simpson R.J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 2010, 9:197-208.
47. Tauro B.J., Greening D.W., Mathias R.A., Ji H., Mathivanan S., Scott A.M., et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 2012, 56:293-304.
48. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995, 80:919-927.
49. Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003, 17:476-478.
50. Hulsmans M., Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013, 100:7-18.
51. Wang T., Gilkes D.M., Takano N., Xiang L., Luo W., Bishop C.J., et al. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci USA 2014, 111:E3234-E3242.
52. Antonyak M.A., Cerione R.A. Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol 2014, 1165:147-173.
53. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010, 123:1603-1611.
54. Whiteside T.L. Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system. Br J Cancer 2005, 92:209-211.
55. Li B., Antonyak M.A., Zhang J., Cerione R.A. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 2012, 31:4740-4749.
56. Muralidharan-Chari V., Clancy J., Plou C., Romao M., Chavrier P., Raposo G., et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009, 19:1875-1885.
57. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
58. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007, 21:157-171.
59. Pap E., Pallinger E., Pasztoi M., Falus A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009, 58:1-8.
60. Lima L.G., Chammas R., Monteiro R.Q., Moreira M.E., Barcinski M.A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 2009, 283:168-175.
61. Barteneva N.S., Fasler-Kan E., Bernimoulin M., Stern J.N., Ponomarev E.D., Duckett L., et al. Circulating microparticles: square the circle. BMC Cell Biol 2013, 14:23.
62. Del Conde I., Shrimpton C.N., Thiagarajan P., Lopez J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005, 106:1604-1611.
63. Crespin M., Vidal C., Picard F., Lacombe C., Fontenay M. Activation of PAK1/2 during the shedding of platelet microvesicles. Blood Coagul Fibrinolysis 2009, 20:63-70.
64. Cussac D., Leblanc P., L'Heritier A., Bertoglio J., Lang P., Kordon C., et al. Rho proteins are localized with different membrane compartments involved in vesicular trafficking in anterior pituitary cells. Mol Cell Endocrinol 1996, 119:195-206.
65. Schlienger S., Campbell S., Claing A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol Biol Cell 2014, 25:17-29.
66. D'Souza-Schorey C., Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006, 7:347-358.
67. D'Asti E., Garnier D., Lee T.H., Montermini L., Meehan B., Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol 2012, 3:294.
68. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
69. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008, 10:619-624.
70. Demory Beckler M., Higginbotham J.N., Franklin J.L., Ham A.J., Halvey P.J., Imasuen I.E., et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 2013, 12:343-355.
71. Camacho L., Guerrero P., Marchetti D. MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLOS ONE 2013, 8:e73790.
72. Hessvik N.P., Phuyal S., Brech A., Sandvig K., Llorente A. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim Biophys Acta 2012, 1819:1154-1163.
73. Choi D.S., Kim D.K., Kim Y.K., Gho Y.S. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013, 13:1554-1571.
74. Llorente A., Skotland T., Sylvanne T., Kauhanen D., Rog T., Orlowski A., et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta 2013, 1831:1302-1309.
75. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9:4997-5000.
76. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012, 10:e1001450.
77. Kim D.K., Kang B., Kim O.Y., Choi D.S., Lee J., Kim S.R., et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles 2013, 2.
78. Choi D.S., Kim D.K., Kim Y.K., Gho Y.S. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev 2014.
79. D'Souza-Schorey C., Di Vizio D. Biology and proteomics of extracellular vesicles: harnessing their clinical potential. Expert Rev Proteomics 2014, 11:251-253.
80. D'Souza-Schorey C., Clancy J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012, 26:1287-1299.
81. Muturi H.T., Dreesen J.D., Nilewski E., Jastrow H., Giebel B., Ergun S., et al. Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior. PLOS ONE 2013, 8:e74654.
82. Garnier D., Magnus N., Meehan B., Kislinger T., Rak J. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res 2013, 319:2747-2757.
83. Corrado C., Raimondo S., Chiesi A., Ciccia F., De Leo G., Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013, 14:5338-5366.
84. Tauro B.J., Greening D.W., Mathias R.A., Mathivanan S., Ji H., Simpson R.J. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 2013, 12:587-598.
85. Braschler U., Shiner J., Streit J., Spenger C., Luscher H.R. Simulation of action potential propagation in terminal arborizations of cultured sensory ganglia. Schweiz Arch Neurol Psychiatr 1989, 140:13-18.
86. Pols M.S., Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res 2009, 315:1584-1592.
87. Abache T., Le Naour F., Planchon S., Harper F., Boucheix C., Rubinstein E. The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells. J Cell Biochem 2007, 102:650-664.
88. Holleman J., Marchese A. The ubiquitin ligase deltex-3l regulates endosomal sorting of the G protein-coupled receptor CXCR4. Mol Biol Cell 2014, 25:1892-1904.
89. van Niel G., Charrin S., Simoes S., Romao M., Rochin L., Saftig P., et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell 2011, 21:708-721.
90. Cheng L., Sharples R.A., Scicluna B.J., Hill A.F. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 2014, 3.
91. Gezer U., Ozgur E., Cetinkaya M., Isin M., Dalay N. Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Int 2014, 38:1076-1079.
92. Balaj L., Lessard R., Dai L., Cho Y.J., Pomeroy S.L., Breakefield X.O., et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011, 2:180.
93. Kahlert C., Melo S.A., Protopopov A., Tang J., Seth S., Koch M., et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014, 289:3869-3875.
94. Thakur B.K., Zhang H., Becker A., Matei I., Huang Y., Costa-Silva B., et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 2014, 24:766-769.
95. Lee T.H., Chennakrishnaiah S., Audemard E., Montermini L., Meehan B., Rak J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 2014, 451:295-301.
96. Morelli A.E., Larregina A.T., Shufesky W.J., Sullivan M.L., Stolz D.B., Papworth G.D., et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004, 104:3257-3266.
97. Wei Y., Lai X., Yu S., Chen S., Ma Y., Zhang Y., et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 2014, 147:423-431.
98. Feng D., Zhao W.L., Ye Y.Y., Bai X.C., Liu R.Q., Chang L.F., et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic 2010, 11:675-687.
99. Christianson H.C., Svensson K.J., van Kuppevelt T.H., Li J.P., Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci USA 2013, 110:17380-17385.
100. Mulcahy L.A., Pink R.C., Carter D.R. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 2014, 3.
101. Svensson K.J., Christianson H.C., Wittrup A., Bourseau-Guilmain E., Lindqvist E., Svensson L.M., et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 2013, 288:17713-17724.
102. Di Vizio D., Kim J., Hager M.H., Morello M., Yang W., Lafargue C.J., et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 2009, 69:5601-5609.
103. Zucker S., Cao J., Chen W.T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000, 19:6642-6650.
104. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003, 160:267-277.
105. Oppel F., Muller N., Schackert G., Hendruschk S., Martin D., Geiger K.D., et al. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. Mol Cancer 2011, 10:137.
106. Yilmaz M., Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010, 8:629-642.
107. Hager M.H., Morley S., Bielenberg D.R., Gao S., Morello M., Holcomb I.N., et al. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med 2012, 4:743-760.
108. Josson S., Gururajan M., Sung S.Y., Hu P., Shao C., Zhau H.E., et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene 2014, 28. 10.1038/onc.2014.212.
109. Tahir S.A., Ren C., Timme T.L., Gdor Y., Hoogeveen R., Morrisett J.D., et al. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res 2003, 9:3653-3659.
110. Wright P.K., Jones S.B., Ardern N., Ward R., Clarke R.B., Sotgia F., et al. 17beta-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget 2014, 5:3055-3065.
111. Minciacchi VR, You S, Spinelli C, Morley S, Zandian M, Aspuria P, et al., Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles, Oncotarget, in press.
112. Webber J., Steadman R., Mason M.D., Tabi Z., Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 2010, 70:9621-9630.
113. Webber J.P., Spary L.K., Sanders A.J., Chowdhury R., Jiang W.G., Steadman R., et al. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene 2014, 15(34):290-302.
114. Antonyak M.A., Li B., Boroughs L.K., Johnson J.L., Druso J.E., Bryant K.L., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 2011, 108:4852-4857.
115. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
116. Thompson C.A., Purushothaman A., Ramani V.C., Vlodavsky I., Sanderson R.D. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013, 288:10093-10099.
117. Szajnik M., Czystowska M., Szczepanski M.J., Mandapathil M., Whiteside T.L. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLOS ONE 2010, 5:e11469.
118. Hakulinen J., Sankkila L., Sugiyama N., Lehti K., Keski-Oja J. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J Cell Biochem 2008, 105:1211-1218.
119. Lv M.M., Zhu X.Y., Chen W.X., Zhong S.L., Hu Q., Ma T.F., et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol 2014, 35:10773-10779.
120. Chen W.X., Liu X.M., Lv M.M., Chen L., Zhao J.H., Zhong S.L., et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLOS ONE 2014, 9:e95240.
121. Cai J., Han Y., Ren H., Chen C., He D., Zhou L., et al. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol 2013, 5:227-238.
122. Tadokoro H., Umezu T., Ohyashiki K., Hirano T., Ohyashiki J.H. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 2013, 288:34343-34351.
123. Le M.T., Hamar P., Guo C., Basar E., Perdigao-Henriques R., Balaj L., et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J Clin Investig 2014, 124:5109-5128.
124. Castellana D., Zobairi F., Martinez M.C., Panaro M.A., Mitolo V., Freyssinet J.M., et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 2009, 69:785-793.
125. Luga V., Zhang L., Viloria-Petit A.M., Ogunjimi A.A., Inanlou M.R., Chiu E., et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151:1542-1556.
126. Shimoda M., Principe S., Jackson H.W., Luga V., Fang H., Molyneux S.D., et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat Cell Biol 2014, 16:889-901.
127. Kosaka N., Iguchi H., Hagiwara K., Yoshioka Y., Takeshita F., Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 2013, 288:10849-10859.
128. Al-Nedawi K., Meehan B., Kerbel R.S., Allison A.C., Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009, 106:3794-3799.
129. Zhuang G., Wu X., Jiang Z., Kasman I., Yao J., Guan Y., et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012, 31:3513-3523.
130. Taylor D.D., Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 2011, 33:441-454.
131. Abusamra A.J., Zhong Z., Zheng X., Li M., Ichim T.E., Chin J.L., et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 2005, 35:169-173.
132. Huber V., Fais S., Iero M., Lugini L., Canese P., Squarcina P., et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005, 128:1796-1804.
133. Kim J.W., Wieckowski E., Taylor D.D., Reichert T.E., Watkins S., Whiteside T.L. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 2005, 11:1010-1020.
134. Clayton A., Mitchell J.P., Court J., Linnane S., Mason M.D., Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 2008, 180:7249-7258.
135. Choi D.Y., You S., Jung J.H., Lee J.C., Rho J.K., Lee K.Y., et al. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment. Proteomics 2014, 14:1845-1856.
136. Ma X., Chen Z., Hua D., He D., Wang L., Zhang P., et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci USA 2014, 111:6389-6394.
137. Chen W.X., Cai Y.Q., Lv M.M., Chen L., Zhong S.L., Ma T.F., et al. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol 2014, 35:9649-9659.
138. Grange C., Tapparo M., Collino F., Vitillo L., Damasco C., Deregibus M.C., et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011, 71:5346-5356.
139. Chevillet J.R., Kang Q., Ruf I.K., Briggs H.A., Vojtech L.N., Hughes S.M., et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 2014, 111:14888-14893.
140. Cvjetkovic A., Lotvall J., Lasser C. The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J Extracell Vesicles 2014, 3.
141. Witwer K.W., Buzas E.I., Bemis L.T., Bora A., Lasser C., Lotvall J., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013, 2.
142. Kalra H., Adda C.G., Liem M., Ang C.S., Mechler A., Simpson R.J., et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 2013, 13:3354-3364.
143. Shao H., Chung J., Balaj L., Charest A., Bigner D.D., Carter B.S., et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 2012, 18:1835-1840.
144. Yoshioka Y., Konishi Y., Kosaka N., Katsuda T., Kato T., Ochiya T. Comparative marker analysis of extracellular vesicles in different human cancer types. J Extracell Vesicles 2013, 2.
145. van der Vlist E.J., Nolte-'t Hoen E.N., Stoorvogel W., Arkesteijn G.J., Wauben M.H. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc 2012, 7:1311-1326.
146. Wright M. Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. Methods Mol Biol 2012, 906:511-524.
147. Kang M.H., Park M.J., Yoo H.J., hyuk K.Y., Lee S.G., Kim S.R., et al. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Eur J Pharm Biopharm 2014, 87:489-499.
148. Corcoran C., Rani S., O'Driscoll L. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 2014, 74:1320-1334.
149. Valencia K., Luis-Ravelo D., Bovy N., Anton I., Martinez-Canarias S., Zandueta C., et al. miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol 2014, 8:689-703.
150. Cheng L., Sun X., Scicluna B.J., Coleman B.M., Hill A.F. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 2014, 86:433-444.
151. Li M., Zeringer E., Barta T., Schageman J., Cheng A., Vlassov A.V. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philos Trans R Soc Lond Ser B: Biol Sci 2014, 369.